Algorithms of using valproic acid drugs in women
Author:
- 1 January 2015
- journal article
- review article
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 115 (4) , 36
Abstract
Characteristics of using valproic acid drugs in women, from puberty to menopause period, are reviewed. Based on initial treatment efficacy, type of epileptic seizures and a form of epilepsy, the author emphasizes the practical use of valproates during pregnancy in dependence on the situation. Several scenarios of pregnancy course and possible treatment tactics are presented.Keywords
This publication has 18 references indexed in Scilit:
- Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6yearsEpilepsy & Behavior, 2013
- Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood AutismJAMA, 2013
- Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational studyThe Lancet Neurology, 2013
- Fetal antiepileptic drug exposure: Motor, adaptive, and emotional/behavioral functioning at age 3yearsEpilepsy & Behavior, 2011
- Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepineArchives of Disease in Childhood, 2011
- Antiepileptic drug use in women of childbearing ageEpilepsy & Behavior, 2009
- AUTISM SPECTRUM DISORDERS FOLLOWING IN UTERO EXPOSURE TO ANTIEPILEPTIC DRUGSNeurology, 2008
- Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohortsEpilepsy Research, 2008
- Intellectual and language functions in children of mothers with epilepsyEpilepsia, 2007
- Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy RegisterJournal of Neurology, Neurosurgery & Psychiatry, 2006